Literature DB >> 18444242

Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc.

Upal K Basu Roy1, Rebecca S Henkhaus, Natalia A Ignatenko, Jessica Mora, Kimberly E Fultz, Eugene W Gerner.   

Abstract

Genetic evidence suggests that caveolin-1, an essential component of membrane caveolae, acts as a tumor promoter in some, and a tumor suppressor in other cancers. The role of caveolin-1 in colon carcinogenesis is controversial. We report here, for the first time, that caveolin-1 is transcriptionally induced in colon cancer cells in response to conditional expression of a full length adenomatous polyposis coli (APC) gene. This induction of caveolin-1 by APC is mediated by both FOXO1a, a member of the Forkhead family of transcription factor, and c-myc. The FOXO1a protein, which is increased by wild-type APC expression, induces caveolin-1 promoter-reporter activity and binds directly to a FKHR consensus binding sequence in the caveolin-1 promoter. The c-myc protein, which is reduced in the presence of wild-type APC, acts to repress caveolin-1 expression by acting at non-E-box containing elements in the caveolin-1 promoter. These data predict that caveolin-1 protein expression would be decreased early in colonic carcinogenesis, which is associated with loss of wild-type APC. Our results would be consistent with the interpretation that caveolin-1 may have tumor suppressing functions during early stages of colon carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18444242      PMCID: PMC4847746          DOI: 10.1002/mc.20451

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  34 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

3.  Apoptosis and APC in colorectal tumorigenesis.

Authors:  P J Morin; B Vogelstein; K W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.

Authors:  B Razani; Y Altschuler; L Zhu; R G Pestell; K E Mostov; M P Lisanti
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

5.  Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements.

Authors:  Arvind Dasari; Janine N Bartholomew; Daniela Volonte; Ferruccio Galbiati
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

6.  Transformation of mammary epithelial cells by 3-phosphoinositide- dependent protein kinase-1 activates beta-catenin and c-Myc, and down-regulates caveolin-1.

Authors:  Zhihui Xie; Xiao Zeng; Todd Waldman; Robert I Glazer
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

Review 7.  Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty.

Authors:  Boudewijn M T Burgering; René H Medema
Journal:  J Leukoc Biol       Date:  2003-06       Impact factor: 4.962

8.  Direct control of caveolin-1 expression by FOXO transcription factors.

Authors:  A Pieter J van den Heuvel; Almut Schulze; Boudewijn M T Burgering
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

9.  Activated K-RAS increases polyamine uptake in human colon cancer cells through modulation of caveolar endocytosis.

Authors:  Upal K Basu Roy; Nathaniel S Rial; Karen L Kachel; Eugene W Gerner
Journal:  Mol Carcinog       Date:  2008-07       Impact factor: 4.784

10.  Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.

Authors:  Elke Burgermeister; Lilach Tencer; Mordechai Liscovitch
Journal:  Oncogene       Date:  2003-06-19       Impact factor: 9.867

View more
  16 in total

1.  Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings.

Authors:  Ettickan Boopathi; Cristiano Mendes Gomes; Robert Goldfarb; Mary John; Vittala Gopal Srinivasan; Jaber Alanzi; S Bruce Malkowicz; Hasmeena Kathuria; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Regulation of the metabolite profile by an APC gene mutation in colorectal cancer.

Authors:  Tomoo Yoshie; Shin Nishiumi; Yoshihiro Izumi; Aya Sakai; Jun Inoue; Takeshi Azuma; Masaru Yoshida
Journal:  Cancer Sci       Date:  2012-04-12       Impact factor: 6.716

3.  Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.

Authors:  Ji Hoon Jung; Deok-Beom Jung; Hyunseok Kim; Hyemin Lee; Shi-Eun Kang; Sanjay K Srivastava; Miyong Yun; Sung-Hoon Kim
Journal:  Oncogene       Date:  2018-04-09       Impact factor: 9.867

4.  Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesis.

Authors:  Richard C Crist; Jacquelyn J Roth; Michael P Lisanti; Linda D Siracusa; Arthur M Buchberg
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

5.  Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis.

Authors:  Upal K Basu Roy; Rebecca S Henkhaus; Fotios Loupakis; Chiara Cremolini; Eugene W Gerner; Natalia A Ignatenko
Journal:  Int J Cancer       Date:  2013-02-12       Impact factor: 7.396

6.  Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines.

Authors:  Karin A Sloan; Hector A Marquez; Jun Li; Yuxia Cao; Anne Hinds; Carl J O'Hara; Satinder Kathuria; Maria I Ramirez; Mary C Williams; Hasmeena Kathuria
Journal:  Carcinogenesis       Date:  2009-05-29       Impact factor: 4.944

Review 7.  Current concepts in colorectal cancer prevention.

Authors:  Patricia A Thompson; Eugene W Gerner
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2009-08       Impact factor: 3.869

8.  Mitochondria-localized caveolin in adaptation to cellular stress and injury.

Authors:  Heidi N Fridolfsson; Yoshitaka Kawaraguchi; Sameh S Ali; Mathivadhani Panneerselvam; Ingrid R Niesman; J Cameron Finley; Sarah E Kellerhals; Michael Y Migita; Hideshi Okada; Ana L Moreno; Michelle Jennings; Michael W Kidd; Jacqueline A Bonds; Ravi C Balijepalli; Robert S Ross; Piyush M Patel; Atsushi Miyanohara; Qun Chen; Edward J Lesnefsky; Brian P Head; David M Roth; Paul A Insel; Hemal H Patel
Journal:  FASEB J       Date:  2012-08-02       Impact factor: 5.191

Review 9.  FOXO1: Another avenue for treating digestive malignancy?

Authors:  Feiyu Shi; Tian Li; Zhi Liu; Kai Qu; Chengxin Shi; Yaguang Li; Qian Qin; Liang Cheng; Xin Jin; Tianyu Yu; Wencheng Di; Jianwen Que; Hongping Xia; Junjun She
Journal:  Semin Cancer Biol       Date:  2017-09-28       Impact factor: 15.707

Review 10.  Cancer chemoprevention locks onto a new polyamine metabolic target.

Authors:  Eugene W Gerner
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.